Sambi Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 04-11-2024
- Paid Up Capital ₹ 6.00 M
as on 04-11-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.84 Cr
as on 04-11-2024
- Revenue -15.69%
(FY 2023)
- Profit -89.84%
(FY 2023)
- Ebitda -64.20%
(FY 2023)
- Net Worth 6.69%
(FY 2023)
- Total Assets 129.83%
(FY 2023)
About Sambi Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹7.84 Cr.
Sandesh Korandla, Hanmanth Reddy, Krishnareddy Sambireddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999TG2019PTC132115
- Company No.
132115
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sambi Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandesh Korandla  | Director | 18-Apr-2019 | Current |
| Hanmanth Reddy | Director | 18-Apr-2019 | Current |
| Krishnareddy Sambireddy | Director | 18-Apr-2019 | Current |
| Madhavi Sambireddy | Director | 18-Apr-2019 | Current |
| Venkat Sambi | Director | 18-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Sambi Pharma.
Sambi Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.69% decrease. The company also saw a substantial fall in profitability, with a 89.84% decrease in profit. The company's net worth moved up by a moderate rise of 6.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sambi Pharma?
In 2023, Sambi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sambi Life Sciences Private LimitedActive 3 years 11 monthsSandesh Korandla, Hanmanth Reddy and 3 more are mutual person
- Mn Gachibowli Ii Tech Park Private LimitedActive 14 years 8 months
Hanmanth Reddy and Venkat Sambi are mutual person
- Sambtek Forex LimitedActive 26 years 11 months
Krishnareddy Sambireddy, Madhavi Sambireddy and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 04 May 2024 | ₹2.50 Cr | Open |
Canara Bank Creation Date: 08 Dec 2023 | ₹8.00 M | Open |
Hdfc Bank Limited Creation Date: 28 Jul 2022 | ₹1.16 M | Open |
How Many Employees Work at Sambi Pharma?
Sambi Pharma has a workforce of 45 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sambi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sambi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
